These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 38159260)
1. Prognostic significance and immunological role of HPRT1 in human cancers. Lu Y; Chen R; Zhang H; Sun X; Li X; Yang M; Zhang X Biomol Biomed; 2024 Mar; 24(2):262-291. PubMed ID: 38159260 [TBL] [Abstract][Full Text] [Related]
2. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers. Wang N; Zhu L; Wang L; Shen Z; Huang X Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736 [TBL] [Abstract][Full Text] [Related]
3. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures. Zhang X; Wang Y; A G; Qu C; Chen J Front Immunol; 2021; 12():721030. PubMed ID: 34531868 [TBL] [Abstract][Full Text] [Related]
4. Identifies microtubule-binding protein Wang W; Zhang J; Wang Y; Xu Y; Zhang S Comput Struct Biotechnol J; 2022; 20():3322-3335. PubMed ID: 35832625 [TBL] [Abstract][Full Text] [Related]
5. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer]. Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766 [No Abstract] [Full Text] [Related]
6. The molecular feature of macrophages in tumor immune microenvironment of glioma patients. Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502 [TBL] [Abstract][Full Text] [Related]
7. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas. Zhao S; Li Y; Xu J; Shen L Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705 [TBL] [Abstract][Full Text] [Related]
8. A Systematic Pan-Cancer Analysis of YY1 Aberrations and their Relationship with Clinical Outcome, Tumor Microenvironment, and Therapeutic Targets. Fu X; Ji F; He Q; Qiu X J Immunol Res; 2022; 2022():5826741. PubMed ID: 35791393 [TBL] [Abstract][Full Text] [Related]
9. Violations of proportional hazard assumption in Cox regression model of transcriptomic data in TCGA pan-cancer cohorts. Zeng Z; Gao Y; Li J; Zhang G; Sun S; Wu Q; Gong Y; Xie C Comput Struct Biotechnol J; 2022; 20():496-507. PubMed ID: 35070171 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of HPRT1 is associated with poor prognosis in head and neck squamous cell carcinoma. Ahmadi M; Eftekhari Kenzerki M; Akrami SM; Pashangzadeh S; Hajiesmaeili F; Rahnavard S; Habibipour L; Saffarzadeh N; Mousavi P FEBS Open Bio; 2021 Sep; 11(9):2525-2540. PubMed ID: 34231338 [TBL] [Abstract][Full Text] [Related]
11. HPRT1 Promotes Chemoresistance in Oral Squamous Cell Carcinoma via Activating MMP1/PI3K/Akt Signaling Pathway. Wu T; Jiao Z; Li Y; Su X; Yao F; Peng J; Chen W; Yang A Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205603 [TBL] [Abstract][Full Text] [Related]
12. Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis. Gao ZW; Yang L; Liu C; Wang X; Guo WT; Zhang HZ; Dong K Front Immunol; 2022; 13():903461. PubMed ID: 35663977 [TBL] [Abstract][Full Text] [Related]
13. Advancing Pan-cancer Gene Expression Survial Analysis by Inclusion of Non-coding RNA. Ye B; Shi J; Kang H; Oyebamiji O; Hill D; Yu H; Ness S; Ye F; Ping J; He J; Edwards J; Zhao YY; Guo Y RNA Biol; 2020 Nov; 17(11):1666-1673. PubMed ID: 31607216 [TBL] [Abstract][Full Text] [Related]
14. HIF-1α-HPRT1 axis promotes tumorigenesis and gefitinib resistance by enhancing purine metabolism in EGFR-mutant lung adenocarcinoma. Geng P; Ye F; Dou P; Hu C; He J; Zhao J; Li Q; Bao M; Li X; Liu X; Xu G J Exp Clin Cancer Res; 2024 Sep; 43(1):269. PubMed ID: 39343971 [TBL] [Abstract][Full Text] [Related]
15. Systematic pan-cancer analyses of the potential function of the Golgi scaffold protein PAQR3. Ling ZN; Hong LL; Wu J; Ling ZQ Sci Rep; 2024 Feb; 14(1):3030. PubMed ID: 38321173 [TBL] [Abstract][Full Text] [Related]
16. PreMSIm: An R package for predicting microsatellite instability from the expression profiling of a gene panel in cancer. Li L; Feng Q; Wang X Comput Struct Biotechnol J; 2020; 18():668-675. PubMed ID: 32257050 [TBL] [Abstract][Full Text] [Related]
17. Bioinformatic Analysis Reveals Bone Marrow Kinase as a Potential Diagnostic and Prognostic Biomarker for Multiple Cancer Types. Khalafallah SA; Eltayeb Ahmed EA; Elnour LS; Mohammed R; Makawi A; Mohamed AK; Balla A; Alamin MF; Alfaki M Cureus; 2024 Aug; 16(8):e68093. PubMed ID: 39347140 [TBL] [Abstract][Full Text] [Related]
18. LINC01614 is a promising diagnostic and prognostic marker in HNSC linked to the tumor microenvironment and oncogenic function. Tian X; Hu D; Wang N; Zhang L; Wang X Front Genet; 2024; 15():1337525. PubMed ID: 38655053 [TBL] [Abstract][Full Text] [Related]
19. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma. Sun K; Chen RX; Li JZ; Luo ZX Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179 [TBL] [Abstract][Full Text] [Related]
20. Integrative omics analysis reveals relationships of genes with synthetic lethal interactions through a pan-cancer analysis. Guo L; Li S; Qian B; Wang Y; Duan R; Jiang W; Kang Y; Dou Y; Yang G; Shen L; Wang J; Liang T Comput Struct Biotechnol J; 2020; 18():3243-3254. PubMed ID: 33240468 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]